Načítá se...
Lusutrombopag increases hematocytes in a compensated liver cirrhosis patient
A 56-year-old Japanese man with liver cirrhosis (LC) due to hepatitis C virus was admitted to our hospital for radiofrequency ablation of residual tumor following lusutrombopag administration. Laboratory tests revealed thrombocytopenia and leukopenia. The patient’s LC was managed, and he was classif...
Uloženo v:
Vydáno v: | Clin J Gastroenterol |
---|---|
Hlavní autoři: | , , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Springer Japan
2017
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5429890/ https://ncbi.nlm.nih.gov/pubmed/28324272 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12328-017-0735-2 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|